A largely random AAV integration profile after LPLD gene therapy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 23770691.
- Also identified by DOI 10.1038/nm.3230.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The clinical application of adeno-associated virus vectors (AAVs) is limited because of concerns about AAV integration-mediated tumorigenicity. We performed integration-site analysis after AAV1-LPL(S447X) intramuscular injection in five lipoprotein lipase-deficient subjects, revealing random nuclear integration and hotspots in mitochondria. We conclude that AAV integration is potentially safe and that vector breakage and integration may occur from each position of the vector genome. Future viral integration-site analyses should include the mitochondrial genome.
Medical subject headings
- Dependovirus
- Genetic Therapy
- Hyperlipoproteinemia Type I
- Virus Integration